Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reversal periods and patterns from drug-resistant to wild-type HIV type 1 after cessation of anti-HIV therapy.

AIDS research and human retroviruses - 1 Jan 2007

Bi Xiuqiong, Gatanaga Hiroyuki, Koike Kazuhiko, Kimura Satoshi, Oka Shinichi

Abstract excerpt

Anti-HIV drug-resistant virus reverts to wild type following discontinuation of antiretroviral therapy (ART). This study aimed to determine the reversal period. ART was discontinued in 16 patients harboring drug-resistant viruses. Resistant mutations of reverse transcriptase (RT) and protease (PR) genes of plasma- and peripheral blood mononuclear cells (PBMC)-derived viruses were examined by direct sequencing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Administration Schedule

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Infections

Share to Leukocytes, Mononuclear

Share to Mutation

Share to Time Factors

Source

Identifiers

PMID: 17263631
DOI: 10.1089/aid.2005.0029

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reversal periods and patterns from drug-resistant to wild-type HIV type 1 after cessation of anti-HIV therapy.PMID 17263631Read ↗

Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy.Semantic proximity Read ↗

Kinetics of HIV-1 RNA and resistance-associated mutations after cessation of antiretroviral combination therapy.Semantic proximity Read ↗

Reappearance of HIV multidrug-resistance in plasma and circulating lymphocytes after reintroduction of antiretroviral therapy.Semantic proximity Read ↗

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy.Semantic proximity Read ↗

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapySemantic proximity Read ↗

Evolution of human immunodeficiency virus type 1 populations after resumption of therapy following treatment interruption and shift in resistance genotype.Semantic proximity Read ↗

HIV-1 re-suppression on a first-line regimen despite the presence of phenotypic drug resistance.Semantic proximity Read ↗

Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure.Semantic proximity Read ↗

Reappearance of an 11-year-old sequence in an HIV-1 infected patient during treatment interruption.Semantic proximity Read ↗

Long-lasting persistence of integrase resistance mutations in HIV-2-infected patients after raltegravir withdrawal.Semantic proximity Read ↗

Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype.Semantic proximity Read ↗

Comparison of the dynamics of resistance-associated mutations to nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors after cessation of antiretroviral combination therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.